KULA, Maui, Hawaii, May 03, 2007 /PRNewswire-FirstCall/ --
Bioponic Phytoceuticals, Inc. ("Bioponic" or "the Company") today announced that its Curecumin(TM) (a Bioresonant Phytotherapeutic(R) form of curcumin in a liquid delivery system) may be an important treatment for Skin Cancer.
In a recent study published in the Journal of Biological Chemistry, "Curcumin Suppresses AP1 Transcription Factor-dependent Differentiation and Activates Apoptosis in Human Epidermal Keratinocytes," conducted at the Departments of Physiology and Biophysics, Dermatology, Biochemistry, Reproductive Biology, and Oncology, at School of Medicine in Cleveland, Ohio. Scientists concluded, "The diet-derived cancer preventive agent, curcumin, inhibits skin cancer cell proliferation and tumor formation ... We show that curcumin suppresses the differentiation agent-dependent activation of hINV gene expression and that an AP1 transcription factor DNA binding site in the hINV gene is required for this regulation ... These studies provide important insights regarding the mechanism whereby curcumin acts as a chemopreventive agent in normal human epidermis."
"We are particularly interested in the potential of our Curecumin(TM) (see http://www.curecumin.com) product to provide a viable treatment strategy for those with skin cancer. Especially, because the form of Curecumin, in a liquid delivery system, will send the formula directly to the skin. If proven effective, we may have an efficacious, cost effective, natural treatment for skin cancer sufferers. We have also included this important ingredient in our popular topical skin care product Hawaiian Healing Mist(TM)," said Steven M. Schorr, Chairman & CEO (see http://www.hawaiianhealingmist.com)
Bioponic Phytoceuticals is engaged in the development, production and distribution of Bioresonant Phytotherapeutic(TM) products. The Company has developed several branded product lines (including the nasal spray: Flight Spray(R) (http://www.flightspray.com) and the skincare product Hawaiian Healing Mist(TM)). Bioponic is focused on the production of natural products that are used to promote health and well-being. www.bioponic.com Contact: Steven M. Schorr/CEO, Bioponic Phytoceuticals, , ph: 808-876-1711 email@example.com
All statements other than statements of historical fact included in this press release are "forward-looking statements" within the meaning of federal securities laws. Such forward-looking statements are subject to a number of risks and uncertainties, some of which are beyond the Company's control.
CONTACT: Steven M. Schorr, CEO, Bioponic Phytoceuticals, +1-808-876-1711, firstname.lastname@example.org